Literature DB >> 214682

Epstein-Barr virus early antigen titer by immunofluorescence in microplates. A new semi-automated method based on microtiter system.

A M Favart, M E Lamy, D Allemeersch, G Burtonboy, J Vanoverschelde.   

Abstract

For the titration of antibodies directed against Epstein-Barr Virus early antigen (EBV-EA) we describe a method in microplates with the Microtiter System (Cooke Engineering Co., Alexandria, Va). Using this technique, which allows rapid epidemiological investigations, we have titered anti-EBV-EA antibodies in different groups of patients and controls, and particularly in group which had recent contact with infectious mononucleosis. In this group the percentage of individuals having antibodies directed against the EBV-EA antigen was significantly higher than in the group of controls.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 214682     DOI: 10.1007/bf02121152

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  10 in total

1.  Clinical evaluation of patients with infectious mononucleosis and development of antibodies to the R component of the Epstein-Barr virus-induced early antigen complex.

Authors:  C A Horwitz; W Henle; G Henle; H Schmitz
Journal:  Am J Med       Date:  1975-03       Impact factor: 4.965

2.  Seroepidemiologic study of Epstein-Barr virus infections in a rural community.

Authors:  C V Sumaya; W Henle; G Henle; M H Smith; D LeBlanc
Journal:  J Infect Dis       Date:  1975-04       Impact factor: 5.226

3.  Epstein-Barr virus viral capsid antigen titer by immunofluorescence with microplates: new semiautomated method based on the microtiter system.

Authors:  M E Lamy; A M Favart; G Burtonboy; A Arana
Journal:  J Clin Microbiol       Date:  1977-07       Impact factor: 5.948

Review 4.  Epstein-Barr virus specific diagnostic tests in infectious mononucleosis.

Authors:  W Henle; G E Henle; C A Horwitz
Journal:  Hum Pathol       Date:  1974-09       Impact factor: 3.466

5.  Epstein-Barr virus-related serology in Hodgkin's disease.

Authors:  W Henle; G Henle
Journal:  Natl Cancer Inst Monogr       Date:  1973-05

6.  Antibodies to early antigens induced by Epstein-Barr virus in infectious mononucleosis.

Authors:  W Henle; G Henle; J C Niederman; E Klemola; K Haltia
Journal:  J Infect Dis       Date:  1971-07       Impact factor: 5.226

7.  Demonstration of two distinct components in the early antigen complex of Epstein-Barr virus-infected cells.

Authors:  G Henle; W Henle; G Klein
Journal:  Int J Cancer       Date:  1971-09-15       Impact factor: 7.396

8.  Antibodies to early Epstein-Barr virus-induced antigens in Burkitt's lymphoma.

Authors:  G Henle; W Henle; G Klein; P Gunven; P Clifford; R H Morrow; J L Ziegler
Journal:  J Natl Cancer Inst       Date:  1971-04       Impact factor: 13.506

9.  Endogenous reactivation of Epstein-Barr virus infections.

Authors:  C V Sumaya
Journal:  J Infect Dis       Date:  1977-03       Impact factor: 5.226

10.  Primary Epstein-Barr virus infections in children.

Authors:  C V Sumaya
Journal:  Pediatrics       Date:  1977-01       Impact factor: 7.124

  10 in total
  3 in total

1.  Epstein-barr Virus (EBV) intracellular antigens: factors affecting the patterns of immunofluorescence.

Authors:  A M Favart; M E Lamy; G Burtonboy
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

2.  Epstein-barr virus VCA IgM and EBNA IgG antibodies titered by immunofluorescence in microplates. A semi-automated method based on microtiter system.

Authors:  M E Lamy; A M Favart; M F Leclercq; M Segas; M Mendez; C Lhoir; C Cornu; G Burtonboy
Journal:  Med Microbiol Immunol       Date:  1982       Impact factor: 3.402

3.  Epstein-Barr virus infection in 59 orthotopic liver transplant patients.

Authors:  M E Lamy; A M Favart; C Cornu; M Salizzoni; N Cimadamore; B de Hemptinne; J B Otte
Journal:  Med Microbiol Immunol       Date:  1990       Impact factor: 3.402

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.